Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Elsevier Business Intelligence's 'IN3 Medical Device 360 London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Abstract:
Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announces an outstanding roster of presenting senior global investors for its 'IN3 Medical Device 360 London' medical technology investment and partnering conference, being held April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre, London Kensington.

Elsevier Business Intelligence's 'IN3 Medical Device 360 London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Bridgewater, NJ | Posted on April 6th, 2012

'IN3 Medical Device 360 London' will feature presentations by approximately two dozen early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership, developing innovative new technologies in the areas of cardiovascular biomaterials, cartilage repair, cancer staging, nanotechnology, neurostimulation, infection control, diagnostics, laparoscopic surgery and much more. Presenting companies to date include: AiMedics, Anethon, CellCoTec, Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products, N8 Medical, NUUBO, QSTREAM VASCULAR, Replication Medical, Sapiens Steering Brain Stimulation, SeamVad, Sensible Medical Innovations, Soft Tissue Regeneration, Specialty Scanners, Vantix, and Vascular Flow Technologies.

The conference also will feature an outstanding agenda of panels and networking sessions with industry thought leaders discussing pressing issues facing the global device industry in 2012 and beyond. Participating speakers include: Edward Andrle, VP, Business Development & Strategy, Sorin Group; Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips Healthcare; Aris Constantinides, Investment Director, NBGI Ventures; Bulend Corbacioglu, VP, Business Development and Licensing, Covidien; Townsend Goddard, Director, Business Development & Strategic Planning, Stryker; Victor Higgs, Managing Director, Applied Nanodetectors; Alan O'Connell, Partner, Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Stan Rabinovich, VP, Advanced Technology, Edwards LifeSciences; Thom Rasche, Partner, Earlybird Venture Capital; and Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director, ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Wellington Partners, Delta Partners, Peppermint VIP, and Family Office Fund. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email .

IN3 Medical Device 360 London will be held at the Millennium Gloucester Hotel & Conference Centre, London Kensington. Event co-sponsors to date include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360 events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

####

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

For more information, please click here

Contacts:
Kayleen Kell
949-797-7142


Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

A new way to make microstructured surfaces: Method can produce strong, lightweight materials with specific surface properties July 29th, 2014

Iranian Scientists Use Waste Cotton Fibers to Produce Cellulose Nanoparticles July 29th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014

Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Produced Water Absorbents, Inc. July 9th, 2014

Investments/IPO's/Splits

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Harris & Harris Group Invests in UberSeq, Inc. July 16th, 2014

Harris & Harris Group Portfolio Company D-Wave Systems Closes a $28.4 Million Financing July 14th, 2014

Announcements

A new way to make microstructured surfaces: Method can produce strong, lightweight materials with specific surface properties July 29th, 2014

Iranian Scientists Use Waste Cotton Fibers to Produce Cellulose Nanoparticles July 29th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Production of Toxic Gas Sensor Based on Nanorods July 28th, 2014

Events/Classes

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

NNCO Announces an Interactive Webinar: Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy July 23rd, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE